Marex Group’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Other funds holding LENZ
7IH
Marex Group's LENZ Position: Q3 2026 in Review
Marex Group held its LENZ Therapeutics (LENZ) position steady in Q3 2026 at 16,000 shares worth $61.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1600.
Marex Group first reported a position in LENZ in Q4 2025 and has held it in 4 quarters since. The position peaked at $256K in Q4 2025. 138 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.
- Marex Group held 16,000 shares of LENZ Therapeutics worth $61.4K as of Q3 2026.
- Marex Group left its LENZ Therapeutics share count unchanged in Q3 2026.
- LENZ Therapeutics made up ﹤0.01% of Marex Group's portfolio in Q3 2026, its #1600 holding.
- Marex Group first reported a position in LENZ Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Marex Group's LENZ Therapeutics position peaked at $256K in Q4 2025.
- 138 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.
Based on Marex Group's 13F filing for Q3 2026, filed 16 Nov 2026.